Status:
WITHDRAWN
Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Therapy After Drug Eluting Stent Placement
Lead Sponsor:
Emory University
Collaborating Sponsors:
Medtronic Vascular
Light Lab Imaging, Inc.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Up to 80 years
Brief Summary
Patients who receive drug-coated stents (as opposed to the less frequently used bare metal stents) are currently recommended aspirin plus a thienopyridine such as Plavix, Effient, or Ticlid for one ye...
Detailed Description
There is a need to find a personalized approach to prescribing dual anti-platelet therapy after a stent is placed in a coronary artery. Stenting involves inserting and expanding a metal tube-shaped de...
Eligibility Criteria
Inclusion
- Any patient requiring percutaneous coronary intervention and meeting criteria (as determined by the performing physician) for Endeavor Drug Eluting Stent Placement
Exclusion
- Patients requiring \>1 stent per treated lesion
- ST segment elevation MI (STEMI)
- inability to comply with study follow-up including 12 months of DAPT
- current or planned pregnancy (for women of childbearing age)
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01219894
Start Date
November 1 2010
End Date
December 1 2010
Last Update
November 20 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.